Mantis Photonics
Primary tabs
About your organization / profile
Every year, more than 200 million people lose their vision entirely or partially every year due to age-related macular degeneration or AMD. We believe AMD, together with many other visual and systemic age-related diseases, is preventable. Effective pharmaceutical treatments exist, and more are being developed. The detection and monitoring of these diseases is time-consuming and inaccessible. Due to a shortage of ophthalmologists, visual care can be inaccessible.
We are developing our patented retinal image modality as a new tool for improving the diagnosis and monitoring of retinal, systemic, and neurodegenerative pathologies. The results from our first clinical trial show we can deliver information to ophthalmologists which is currently unavailable.
Network (0)
There are no organizations in the network.
Recent activities
Mantis Photonics has taken its fundraising offline.
The dataroom has been updated.
Mantis Photonics has published its search for partners online: Ophthalmologic device production and distribution.
The pitchdeck document has been updated in the dataroom.
The dataroom has been updated.
Mantis Photonics has published fundraising documents.
Jan Alexander has joined Mantis Photonics .